Clinical Trial Update: Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA) [Phase 2]

View source ↗

Summary

This Phase 2 trial compares elranatamab plus lenalidomide versus daratumumab plus lenalidomide as post-transplant maintenance in newly diagnosed multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Daratumumab (daratumumab)
• Elranatamab (elranatamab)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Nantes University Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: NOT_YET_RECRUITING